H.U. Group Holdings, Inc. (TSE: 4544)
Health Care · Health Care Providers & Services · JP
¥3,580.00
+3.92% today · -3.2% 1Y
H.U. Group Holdings, Inc. (TSE: 4544) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.24B and employs 5,157 people.
Over the last twelve months the share price has lost 3.2%, trading between 2.94K and 4.09K.
Tweenvest scores H.U. Group Holdings, Inc. across four factors: quality 73/100, value 31/100, growth 9/100, dividend 100/100. Its strongest factor is dividend.
4544 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.24B
- Revenue (TTM)
- $1.53B
- P/E
- 20.83
- EPS
- 171.85
- Dividend yield
- 3.49%
- Beta (5Y)
- 0.28
- 52-week high
- ¥4,093.00
- 52-week low
- ¥2,944.50
- Avg volume (3M)
- —
- Shares outstanding
- 55.06M
- Employees
- 5,157
- Next earnings
- —
About H.U. Group Holdings, Inc.
Established in 1950 and headquartered in Tokyo, Japan, H.U. Group Holdings, Inc. (formerly Miraca Holdings Inc. until its rebranding in July 2020) provides an extensive array of laboratory testing products and services through its subsidiaries across Japan. The company delivers diagnostic testing and associated services to medical facilities, supports self-medication initiatives, and conducts testing for food, environmental samples, and cosmetic products. Additionally, it offers testing solutions tailored for corporate health insurance programs. The group is deeply involved in the research, development, manufacturing, and commercialization of in vitro diagnostic devices. Its product lineup features the LUMIPULSE, an automated chemiluminescent enzyme immunoassay system that supplies reagents for the detection of infectious diseases, various cancers, and lifestyle-related conditions to medical institutions and diagnostic centers. H.U. Group also produces the ESPRINE series of rapid diagnostic kits for ailments such as influenza, hepatitis B, and the novel coronavirus, alongside supplying essential ingredients for test drugs. Beyond diagnostics, the company offers crucial support services for hospital administration, including assistance during surgical and endoscope procedures, inspection and maintenance of medical equipment, and in-hospital logistics and transportation management. Furthermore, it addresses the elderly care market by renting and selling specialized equipment and supplies, and by providing in-home nursing care services.
- ISIN
- JP3822000000
- Founded
- 1950
- Listed since
- Jan 1, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Spire Healthcare Group plcLSE: SPI | $1.31B | £2.47 | +0.61% |
| National Medical Care CompanySASE: 4005 | $1.30B | SR108.90 | +6.87% |
| Netcare LimitedJSE: NTC | $1.27B | R17.78 | +2.13% |
| U.S. Physical Therapy, Inc.NYSE: USPH | $1.26B | $86.24 | +1.85% |
| InnovAge Holding Corp.NasdaqGS: INNV | $1.24B | $9.12 | +0.16% |
| Med Life S.A.BVB: M | $1.23B | RON11.08 | +11.36% |
| China Reform Health Management and Services Group Co., Ltd.SZSE: 000503 | $1.23B | CN¥8.43 | +9.62% |
| Ramsay Générale de Santé SAENXTPA: GDS | $1.23B | €9.90 | -0.60% |
Figures last refreshed Oct 11, 2026.